Companies: 10,795·Total market cap: $144.5T
Verve Therapeutics, Inc.

Verve Therapeutics, Inc.

VERVNASDAQHealthcare
$11.13
+$0.03(+0.27%)
Market Cap$994044786
P/E Ratio—
52W High$11.405
52W Low$2.865
Overview

Verve Therapeutics, Inc. (VERV) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · VERV · as of Feb 27, 2025

Latest filing snapshot

274
+19+7.45%vs prior year

Verve Therapeutics, Inc. (VERV) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2024-12-31·Full-time · Global
Total Employees
274
Change (1Y)
+19
Growth % (1Y)
+7.45%
Revenue / Employee
$118.0K
Net Income / Employee
$-725.2K
Market Cap
$994M

VERV Employee Count

2021 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-02-27274+19+7.45%
2024-02-27255+51+25.00%
2023-03-02204+91+80.53%
2022-03-14113——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Avid Bioservices, Inc.
CDMO
Avid Bioservices, Inc.
371#2
EQRx, Inc.
EQRX
EQRx, Inc.
362#3
Gracell Biotechnologies Inc.
GRCL
Gracell Biotechnologies Inc.
314#4
Verve Therapeutics, Inc.
VERV
Verve Therapeutics, Inc.YOU
274#5
Albireo Pharma, Inc.
ALBO
Albireo Pharma, Inc.
130#6
Crescent Biopharma, Inc.
CBIO
Crescent Biopharma, Inc.
41#7
Ethzilla Corp.
ETHZ
Ethzilla Corp.
4
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · VERV peer comparison

About VERV employees

VERV Employees · Headcount

Verve Therapeutics, Inc. (VERV) employee data is sourced from the annual SEC 10-K filing. As of 2024, Verve Therapeutics, Inc. had 274 full-time employees globally. Full-time employees only. Global consolidated headcount.

Verve Therapeutics, Inc. employs 274 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $118,000, reflecting the company's operational efficiency.

Verve Therapeutics, Inc.'s workforce increased by 19 (7.45%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Verve Therapeutics, Inc.'s revenue per employee of $118,000 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

VERV Employees · 5 questions

As of the latest SEC 10-K filing (2024), Verve Therapeutics, Inc. had 274 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Verve Therapeutics, Inc. employee counthow many employees does Verve Therapeutics, Inc. haveVERV total employees 2024

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-02-27